Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 40333005 | 0 | Bucciol R, Parente H, Tera Y, et al. Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics. Blood Coagul Fibrinolysis. 2025 May 6. doi: 10.1097/MBC.0000000000001367. |
2 | 39919489 | 0 | Harry J, Bucciol R, Finnigan D, et al. The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review. Cancer Epidemiol. 2025 Feb 5;95:102764. doi: 10.1016/j.canep.2025.102764. |
3 | 39918903 | 0 | Qian A, Zandi A, Bucciol R, et al. The role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as venous thromboembolism predictors in breast cancer patients pre- and post-therapy. Blood Coagul Fibrinolysis. 2025 Mar 1;36(2):62-67. doi: 10.1097/MBC.0000000000001341. Epub 2025 Jan 2. |
4 | 37935936 | 0 | El-Sayed HA, Othman M, Azzam H, et al. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models. J Cancer Res Clin Oncol. 2023 Dec;149(20):17771-17780. doi: 10.1007/s00432-023-05475-7. Epub 2023 Nov 7. |
5 | 37522480 | 0 | Bucciol R, Othman M. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review. Curr Opin Hematol. 2023 Sep 1;30(5):180-185. doi: 10.1097/MOH.0000000000000774. |